Article

Lopinavir-ritonavir versus darunavir-ritonavir for hospitalized COVID-19 patients

Research square · 2023 · Dóra Paróczai, author András Bikov, author Andreea Blidaru, author Emanuel Bobu, author Iulia Bogdan, author Iosif Marincu, author Stefan Mihaicuta, author Stefan Frent, author

Key facts

Title Lopinavir-ritonavir versus darunavir-ritonavir for hospitalized COVID-19 patients
First author Dóra Paróczai, author András Bikov, author Andreea Blidaru, author Emanuel Bobu, author Iulia Bogdan, author Iosif Marincu, author Stefan Mihaicuta, author Stefan Frent, author
Journal Research square
Published Sep 3, 2023
DOI 10.21203/rs.3.rs-3182924/v1
Product codes mentioned OOI

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature